HOCH LYNELLE 2005382 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | acq | 4351.0 | 100 | 0.02 | 0.0 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code M | 3781.0 | 2022.19 (BMY) |
2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | dsp | 2625.0 | 60.33 | 0.01 | 26.8 | Direct | Common Stock | BRISTOL MYERS SQUIBB CO | code F J | 1726.0 | 2022.19 (BMY) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-12-20 | 2023-12-15 | 3 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | holding | 14587.0 | 0 | 0.07 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | NA | 2034.76 (BMY) | ||
2023-12-20 | 2023-12-15 | 3 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | holding | 8339.0 | 0 | 0.04 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | NA | 2034.76 (BMY) | ||
2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | dsp | 3268.0 | 100.0 | 0.02 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code M | 0.0 | 2022.19 (BMY) |
2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | acq | 7546.0 | 100.0 | 0.04 | 0.0 | Direct | Performance Shares | BRISTOL MYERS SQUIBB CO | code A | 7546.0 | 2022.19 (BMY) |
2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | acq | 5031.0 | 100.0 | 0.02 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code A | 5031.0 | 2022.19 (BMY) |
2024-03-12 | 2024-03-10 | 2024-03-10 | 4 | Hoch Lynelle | PRESIDENT, CELL THERAPY ORG. | dsp | 2968.0 | 48.5 | 0.01 | 0.0 | Direct | Market Share Units | BRISTOL MYERS SQUIBB CO | code J M | 3152.0 | 2022.19 (BMY) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)